You just read:

Genomic Health Announces Upcoming Presentation of Four Oncotype DX® Studies Including New Validation on Its Ability to Predict Prostate Cancer-specific Death and Metastases

News provided by

Genomic Health, Inc.

May 04, 2017, 08:00 ET